Action 002932 WUHAN EASY DIAGNOSIS BIOMEDICINE CO.,LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

Actions

002932

CNE1000033Q7

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 15/05/2024 		Varia. 5j. Varia. 1 janv.
19,96 CNY -1,92% Graphique intraday de Wuhan Easy Diagnosis Biomedicine Co.,Ltd. -5,85% -13,10%
26/04 Wuhan Easy Diagnosis Biomedicine Co. propose un dividende final en espèces pour l'année 2023 CI
27/03 Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) annonce un rachat d'actions pour une valeur de 350 millions CNY. (SZSE:002932) annonce un rachat d'actions pour une valeur de 350 millions CNY. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Proposes Final Cash Dividend for Year 2023
Tranche Update on Wuhan Easy Diagnosis Biomedicine Co.,Ltd.'s Equity Buyback Plan announced on March 28, 2024.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. commences an Equity Buyback Plan for CNY 350 million worth of its shares, under the authorization approved on March 18, 2024.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. authorizes a Buyback Plan.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 06 June 2023
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Approves Dividend for 2022
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Proposes Profit Distribution for 2022
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
China stocks retreat on concerns of surging COVID cases
China stocks retreat on concerns of rising COVID cases
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Announces Executive Elections
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.(XSEC:002932) added to S&P Global BMI Index
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Announces Interim Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 21 September 2022
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Approves Interim Cash Dividend for 2022
Zhuhai Digifluidic Biotechnology Co., Ltd. announced that it has received CNY 100.596565 million in funding from Wuhan Easy Diagnosis Biomedicine Co.,Ltd., Guangzhou Funway Asset Management Co., Ltd., Guangzhou Huiju Xinxing Equity Investment Partnership
Zhuhai Digifluidic Biotechnology Co. announced that it expects to receive CNY 0.747 million in funding from Wuhan Easy Diagnosis Biomedicine Co.,Ltd., Guangzhou Funway Asset Management Co., Ltd., Guangzhou Huiju Xinxing Equity Investment Partnership and another investor
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 002932
  4. Actualités Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
  5. Autres langues